AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
14.41
+0.79 (5.80%)
At close: Mar 9, 2026, 4:00 PM EDT
14.43
+0.02 (0.14%)
After-hours: Mar 9, 2026, 4:04 PM EDT
AgomAb Therapeutics NV Market Cap
AgomAb Therapeutics NV has a market cap or net worth of $702.30 million as of March 9, 2026.
Market Cap
702.30M
Enterprise Value
537.68M
1-Year Change
n/a
Ranking
Category
Stock Price
$14.41
Market Cap Chart
Since the IPO on February 6, 2026, AgomAb Therapeutics NV's market cap has decreased from $779.79M to $702.30M, a decrease of -9.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 663.79M | -14.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prime Medicine | 715.40M |
| Replimune Group | 710.95M |
| ProKidney | 703.95M |
| Jade Biosciences | 702.26M |
| Theravance Biopharma | 696.75M |
| Alto Neuroscience | 651.00M |
| MiMedx Group | 650.72M |
| Zura Bio | 644.20M |